Does Cinnamon Metabolic Health Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Cinnamon Metabolic Health Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) affect adults worldwide and are causes of morbidity. [Chen Liang A (2026); evidence level 1] - Evidence synthesis has been limited by heterogeneity in formulations and study quality. [Chen Liang A (2026); evidence level 1] - Risk of bias was assessed using RoB 2.0, and certainty of evidence using Confidence in NMA. [Chen Liang A (2026); evidence level 1] - While lifestyle modification remains in first-line therapy, interest has emerged in herbal agents with potential hepatometabolic effects. [Chen Liang A (2026); evidence level 1] - Type 2 diabetes is associated with altered microbial composition, reduced butyrate-producing taxa and disrupted metabolic pathways. [Okonta EO (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.